Shosaikoto increases calprotectin expression in human oral epithelial cells

Journal of Periodontal Research

Volumn 45, Issue 1, 2010, Pages 79-86

  Hiroshima, Y ^a   Bando, M ^a   Kataoka, M ^b   Shinohara, Y ^a   Herzberg, M C ^c   Ross, K F ^c   Inagaki, Y ^a   Nagata, T ^a   Kido, J ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antimicrobial peptides; Calprotectin; Epithelial cell; Shosaikoto

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; HERBACEOUS AGENT; IMMUNOLOGIC FACTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA; MESSENGER RNA; SHOSAIKO-TO; XIAO CHAI HU TANG;

ARTICLE; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; HUMAN; METHODOLOGY; MOUTH MUCOSA; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, NORTHERN; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELLS, CULTURED; DRUGS, CHINESE HERBAL; EPITHELIAL CELLS; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-1ALPHA; LEUKOCYTE L1 ANTIGEN COMPLEX; MOUTH MUCOSA; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-1 TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 74549212506     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01203.x     Document Type: Article

References (41)

1. Eversole LR, Miyasaki KT, Christensen RE. The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes. Arch Oral Biol 1992 37 : 963 968.
2. Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998 9 : 399 414.
3. Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005 7 : 119 133.
4. Jana NK, Gray LR, Shugars DC. Human immunodeficiency virus type I stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity. J Virol 2005 79 : 6432 6440.
5. Fagerhol MK, Andersson KB, Naess-Andresen C, Dale I. Calprotectin (the L1 leukocyte protein). In : Smith VL, Dedman JR, eds. Stimulus Response Coupling: the Role of Intracellular Calcium-Binding Proteins. Boca Raton, FL : CRC Press, 1990 : 187 210.
6. Suryono Kido J, Hayashi N, Kataoka M, Nagata T. Effect of Porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-α, and interleukin-1β on calprotectin release in human monocytes. J Periodontol 2003 74 : 1719 1724. (Pubitemid 38181212)
7. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect Immun 2001 69 : 4242 4247.
8. Hayashi N, Kido J, Suryono et al. Regulation of calprotectin expression by interleukin-1α and transforming growth factor-β in human gingival keratinocytes. J Periodont Res 2007 42 : 1 7.
9. Kido J. The role of calprotectin in periodontal diseases and regulation of its expression. J Jpn Soc Periodontol 2007 49 : 13 19.
10. Tajiri H, Kozaiwa K, Ozaki Y, Miki K, Shimuzu K, Okada S. Effect of sho-saiko-to (xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. Am J Chin Med 1991 19 : 121 129.
11. Oka H, Yamamoto S, Kuroki T et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995 76 : 743 749.
12. Ohtake N, Suzuki R, Daikuhara H et al. Modulation of lung local immune response by oral administration of a herbal medicine Sho-saiko-to. Int J Immunopharmacol 2000 22 : 419 430.
13. Borchers AT, Sakai S, Henderson GL et al. Sho-saiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. J Ethnopharmacol 2000 73 : 1 13.
14. Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 2000 15 : D84 90.
15. Ohtake N, Nakai Y, Yamamoto M et al. Separation and isolation methods for analysis of the active principles of Sho-saoko-to (SST) oriental medicine. J Chromatogr B 2004 812 : 135 148.
16. Cheng PW, Ng LT, Lin CC. Xiao Chai Hu Tang inhibits CVS1 virus infection of CCFS-1 cells through the induction of type I interferon expression. Int Immuno pharmacol 2006 6 : 1003 1012.
17. Yamashiki M, Kosaka Y, Nishimura A, Takase K, Ichida F. Efficacy of a herbal medicine "Sho-saiko-to" on the improvement of impaired cytokine production of peripheral blood mononuclear cells in patients with chronic viral hepatitis. J Clin Lab Immunol 1992 37 : 111 121. (Pubitemid 23249693)
18. Huang XX, Yamashiki M, Nakatani K, Nobori T, Mase A. Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a gel doc system. J Clin Lab Anal 2001 15 : 199 209.
19. Yamaoka Y, Kawakita T, Kaneko M, Nomoto K. A polysaccharide fraction of Sho-saiko-to active in augmentation of natural killer activity by oral administration. Biol Pharm Bull 1995 18 : 846 849.
20. Wu JA, Attele AS, Zhang L, Yuan CS. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 2001 29 : 69 81.
21. Zhu K, Fukasawa I, Furuno M et al. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol 2005 97 : 405 409.
22. Matsumoto Y, Kato M, Tamada Y, Mori H, Ohashi M. Enhancement of interleukin-1α mediated autocrine growth of cultured human keratinocytes by Sho-saiko-to. Jpn J Pharmacol 1997 73 : 333 336.
23. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1979 102 : 344 352.
24. Nagatsu Y, Inoue M, Ogihara Y. Modification of macrophage functions by Shosaikoto (Kampo medicine) leads to enhancement of immune response. Chem Pharm Bull (Tokyo) 1989 37 : 1540 1542.
25. Yonekura K, Kawakita T, Mitsuyama M et al. Induction of colony-stimulating factor(s) after administration of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: Sho-saiko-to). Immunopharmacol Immunotoxicol 1990 12 : 647 667.
26. Yamashiki M, Asakawa M, Kayaba Y, Kosaka Y, Nishimura A. Herbal medicine "Sho-saiko-to" induces in vitro granulocyte colony-stimulating factor production on peripheral blood mononuclear cells. J Clin Lab Immunol 1992 37 : 83 90. (Pubitemid 23247625)
27. Yamashiki M, Nishimura A, Suzuki H, Sakaguchi S, Kosaka Y. Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997 25 : 1390 1397. (Pubitemid 27250759)
28. Yamashiki M, Nishimura A, Huang XX, Nobori T, Sakaguchi S, Suzuki H. Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on interleukin-12 production in patients with HCV-positive liver cirrhosis. Dev Immunol 1999 7 : 17 22.
29. Sauder DN, Stanulis-Praeger BM, Gilchrest BA. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging. Arch Dermatol Res 1988 280 : 71 76.
30. Eller MS, Yaar M, Ostrom K, Harkness DD, Gilchrest BA. A role for interleukin-1 in epidermal differentiation: regulation by expression of functional versus decoy receptors. J Cell Sci 1995 108 : 2741 2746.
31. Feliciani C, Gupta AK, Saucier DN. Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med 1996 7 : 300 318.
32. Bando M, Hiroshima Y, Kataoka M et al. Interleukin-1α regulates antimicrobial peptide expression in human keratinocytes. Immunol Cell Biol 2007 85 : 532 537.
33. Ohtake N, Yamamoto M, Takeda S et al. The herbal medicine Sho-saiko-to selectively inhibits CD8+ T-cell proliferation. Eur J Pharmacol 2005 507 : 301 310.
34. Rivera E, Pettersson FE, Inganäs M, Paulie S, Gronvik K. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 2005 23 : 5411 5419.
35. Madsen P, Rasmussen HH, Leffers H et al. Molecular cloning occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991 97 : 701 712.
36. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005 6 : 57 64.
37. Araki N, Noda T, Ogawa K. Cytochemical studies on the effect of intraperitoneal and oral administration of a traditional Chinese medicine (Sho-saiko-to) on the d-galactosamine-induced hepatic injuries of rats. Acta Histochem Cytochem 1988 21 : 439 453.
38. Matsuoka H, Mizushima Y, Kawano M et al. Clinical availability of the herbal medicine, SYOUSAIKOTOU, as a gargling agent for prevention and treatment of chemotherapy-induced stomatitis. Gan To Kagaku Ryoho 2004 31 : 2017 2020.
39. Ara T, Maeda Y, Fujinami Y, Imamura Y, Hattori T, Wang P. Preventive effects of a Kampo medicine, Shosaikoto, on inflammatory responses in LPS-treated human gingival fibroblasts. Biol Pharm Bull 2008 31 : 1141 1144.
40. Chan Y, Lai CH, Yang HW, Lin YY, Chan CH. The evaluation of Chinese herbal medicine effectiveness on periodontal pathogens. Am J Chin Med 2003 31 : 751 761.
41. Shimizu K, Amagaya S, Ogihara Y. Combination effects of Shosaikoto (Chinese traditional medicine) and prednisolone on the anti-inflammatory action. J Pharmacobiodyn 1984 7 : 891 899.